Australian Therapeutic Goods Administration Approves the First...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SHANGHAI and MELBOURNE, Australia, Aug. 13, 2020 /PRNewswire-AsiaNet/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company, announced today the authorization of the first-in-human trial of ATG-017 (ERASER trial) by the Australian Therapeutic Goods Administration (TGA)...
Authors: LATEST ASIANET NEWS RELEASES